Literature DB >> 2959409

Visual and cutaneous toxicity which occurs during N-(4-hydroxyphenyl) retinamide therapy for psoriasis.

T P Kingston, N J Lowe, J Winston, J Heckenlively.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2959409     DOI： 10.1111/j.1365-2230.1986.tb00520.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN： 0307-6938            Impact factor:   3.470


× No keyword cloud information.
  3 in total

1.  The bioactive lipid 4-hydroxyphenyl retinamide inhibits flavivirus replication.

Authors:  Margot Carocci; Stephen M Hinshaw; Mary A Rodgers; Valerie A Villareal; Dominique J Burri; Rajendra Pilankatta; Natalya P Maharaj; Michaela U Gack; Eric J Stavale; Kelly L Warfield; Priscilla L Yang
Journal:  Antimicrob Agents Chemother       Date:  2014-10-13       Impact factor: 5.191

Review 2.  Adverse effects of retinoids.

Authors:  M David; E Hodak; N J Lowe
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Jul-Aug

3.  Phase II study of fenretinide (NSC 374551) in adults with recurrent malignant gliomas: A North American Brain Tumor Consortium study.

Authors:  Vinay K Puduvalli; W K Alfred Yung; Kenneth R Hess; John G Kuhn; Morris D Groves; Victor A Levin; James Zwiebel; Susan M Chang; Timothy F Cloughesy; Larry Junck; Patrick Wen; Frank Lieberman; Charles A Conrad; Mark R Gilbert; Christina A Meyers; Vivien Liu; Minesh P Mehta; M Kelly Nicholas; Michael Prados
Journal:  J Clin Oncol       Date:  2004-11-01       Impact factor: 44.544
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.